ABI was founded in 1989, with the objective of developing proprietary, in vitro diagnostic technologies that accelerate the rate at which clinicians can obtain single-patient results. The tests and sample preparation devices that emerge from our rapid technology platforms are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time.
We our dedicated to the development of time- and cost-efficient, single-use devices that can be utilized almost anytime, anywhere. We believe that our products facilitate more convenient and frequent point-of-care testing which may ultimately save or improve the overall quality of individuals’ lives.
Our rapid diagnostic tests, specifically designed for healthcare applications:
- help facilitate or rule-out diagnoses and provide a targeted pathway for real-time treatment decisions
- provide affordable testing solutions for mass screenings for key infectious diseases, cardiac conditions and metabolic markers, without the use of expensive equipment or lengthy test procedures
Our personal use products enable individuals to monitor their health and wellness with the help of easy-to-perform, often noninvasive methods.